Ali Pooria
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ali Pooria has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Alireza Gheini
Department of Cardiology, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran
6 shared publications Afsoun Pourya
4 shared publications- Afsoun Pourya
Student of Research committee Tehran University of Medical Science Tehran Iran
2 shared publications Hassan Teimouri
Department of Cardiac Surgery , School of Medicine, Lorestan University of Medical Sciences , Khorramabad , Iran
2 shared publications- Mehrdad Namdari
Department of Cardiology, Lorestan University of Medical Sciences, Khoramabad, Iran
2 shared publications - Morteza Azadbakht
Department of Surgery, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
2 shared publications
Latest Publications
- Open Access
- 16 September 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (11) , 7400-7405
Gold nanoparticles in cardiovascular medicine: current applications and future directions in nano-cardiology
Gold nanoparticles (GNPs) are poised to revolutionize the diagnosis and treatment of cardiovascular diseases (CVDs). This review uniquely synthesizes current research by focusing on three critical, interlinked advancements that address key translational challenges in nano-cardiology: (1) the precise engineering of size-optimized GNPs (20–50 nm) to enhance hemodynamic stability and targeted tissue penetration, overcoming limitations of broader size ranges; (2) the development of dual-modality imaging probes specifically designed to leverage macrophage-targeted photoacoustic signals for precise and early detection of vulnerable atherosclerotic plaques, a significant unmet diagnostic need; and (3) the innovation of stimuli-responsive drug delivery systems that exploit GNPs’ tunable surface chemistry to achieve localized and efficient therapeutic effects, thereby minimizing systemic toxicity and improving drug concentrations at diseased sites. We critically examine how these advancements are transforming early CVD detection (e.g., highly sensitive heart attack diagnostics), targeted therapies (e.g., specific drug delivery for heart failure), and regenerative medicine (e.g., enhanced cardiac tissue repair). Finally, we identify current challenges, such as ensuring rigorous biocompatibility and optimizing blood flow interactions, and propose specific, actionable strategies to accelerate the translation of these promising laboratory discoveries into clinical practice, charting a clear path for the next generation of nano-cardiology solutions.
- 16 September 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (11) , 7400-7405
Open AccessGold nanoparticles in cardiovascular medicine: current applications and future directions in nano-cardiology
Gold nanoparticles (GNPs) are poised to revolutionize the diagnosis and treatment of cardiovascular diseases (CVDs). This review uniquely synthesizes current research by focusing on three critical, interlinked advancements that address key translational challenges in nano-cardiology: (1) the precise engineering of size-optimized GNPs (20–50 nm) to enhance hemodynamic stability and targeted tissue penetration, overcoming limitations of broader size ranges; (2) the development of dual-modality imaging probes specifically designed to leverage macrophage-targeted photoacoustic signals for precise and early detection of vulnerable atherosclerotic plaques, a significant unmet diagnostic need; and (3) the innovation of stimuli-responsive drug delivery systems that exploit GNPs’ tunable surface chemistry to achieve localized and efficient therapeutic effects, thereby minimizing systemic toxicity and improving drug concentrations at diseased sites. We critically examine how these advancements are transforming early CVD detection (e.g., highly sensitive heart attack diagnostics), targeted therapies (e.g., specific drug delivery for heart failure), and regenerative medicine (e.g., enhanced cardiac tissue repair). Finally, we identify current challenges, such as ensuring rigorous biocompatibility and optimizing blood flow interactions, and propose specific, actionable strategies to accelerate the translation of these promising laboratory discoveries into clinical practice, charting a clear path for the next generation of nano-cardiology solutions.
- Open Access
- 14 July 2022
- Published by Bentham Science Publishers Ltd. in The Open Public Health Journal
- Vol. 15 (1)
The Relationship Between Incidence of Depression After Myocardial Infarction (MI)
Objective: Depression is predicted to be the leading cause of mortality and morbidities in the next few years. Its association with cardiovascular diseases is well-established from various researches. The aim of this study is to evaluate the incidence of depression of co-morbid psychiatric disorders among patients with a recent history of myocardial infarction (MI). Methods: In this retrospective study, patients with a history of myocardial infarction marked by electrocardiographic (ECG) and enzymatic findings referred to our psychiatric center were included. The MMPI questionnaire was used to evaluate the prevalence of depression along with other psychiatric disorders. SPSS v18 was used to evaluate the data recorded and analyzed from these questionnaires. Results: Of 50 patients studied, the prevalence of depression is the greatest (63%) in patients with anterior septal MI. Furthermore, 26% of women and 24% of men with depression and hysteria were the common comorbidity reported. To it, 15 patients aged 60-69 years had post-MI depression. Conclusion: Our study reports an increased incidence of post-MI depression in the general targeted population. Further investigation and therapeutic measures can decrease future repercussions and the incidence of other cardiovascular events, including recurrent MI.
- 14 July 2022
- Published by Bentham Science Publishers Ltd. in The Open Public Health Journal
- Vol. 15 (1)
Open AccessThe Relationship Between Incidence of Depression After Myocardial Infarction (MI)
Objective: Depression is predicted to be the leading cause of mortality and morbidities in the next few years. Its association with cardiovascular diseases is well-established from various researches. The aim of this study is to evaluate the incidence of depression of co-morbid psychiatric disorders among patients with a recent history of myocardial infarction (MI). Methods: In this retrospective study, patients with a history of myocardial infarction marked by electrocardiographic (ECG) and enzymatic findings referred to our psychiatric center were included. The MMPI questionnaire was used to evaluate the prevalence of depression along with other psychiatric disorders. SPSS v18 was used to evaluate the data recorded and analyzed from these questionnaires. Results: Of 50 patients studied, the prevalence of depression is the greatest (63%) in patients with anterior septal MI. Furthermore, 26% of women and 24% of men with depression and hysteria were the common comorbidity reported. To it, 15 patients aged 60-69 years had post-MI depression. Conclusion: Our study reports an increased incidence of post-MI depression in the general targeted population. Further investigation and therapeutic measures can decrease future repercussions and the incidence of other cardiovascular events, including recurrent MI.
- Open Access
- 3 December 2021
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 72, 103146
Frequency of recurrence of peripheral artery disease among angioplasty and stenting patients
Peripheral artery disease (PAD) is a cardiovascular disease that is characterized by obstruction of peripheral artery. It is associated with comorbidities, reduced quality of life and mortality. The aim of this study was to determine the frequency of recurrence of PAD among patients who underwent angioplasty or stenting and associated risk factors. In this retrospective study, all patients referred to the cardiovascular center of (XXX) with the diagnosis of lower extremity PAD were included. Patients’ demographic information, age, gender, smoking status, history of diabetes, history of hypertension, dyslipidemia, number of vessels, type of stent, recurrence of the disease, and size of the lesion were obtained from the hospital database. Endovascular revascularization therapy was either performed by angioplasty or stenting method. The data were analyzed by SPSS v21. Of 88 patients included in this study, 12.5% were reported with restenosis. Gender, age, size of the lesion, the status of smoking, history of hypertension, and dyslipidemia were not significantly associated with the recurrence of stenosis, p > 0.05. There was a significant relationship between the vessels involved and the type of revascularization method and the recurrence of the PAD. Endovascular revascularization technique and type of vessel involved in PAD are significant factors contributing to restenosis in our population of study. However, further studies with a greater sample size are required in this area.
- 3 December 2021
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 72, 103146
Open AccessFrequency of recurrence of peripheral artery disease among angioplasty and stenting patients
Peripheral artery disease (PAD) is a cardiovascular disease that is characterized by obstruction of peripheral artery. It is associated with comorbidities, reduced quality of life and mortality. The aim of this study was to determine the frequency of recurrence of PAD among patients who underwent angioplasty or stenting and associated risk factors. In this retrospective study, all patients referred to the cardiovascular center of (XXX) with the diagnosis of lower extremity PAD were included. Patients’ demographic information, age, gender, smoking status, history of diabetes, history of hypertension, dyslipidemia, number of vessels, type of stent, recurrence of the disease, and size of the lesion were obtained from the hospital database. Endovascular revascularization therapy was either performed by angioplasty or stenting method. The data were analyzed by SPSS v21. Of 88 patients included in this study, 12.5% were reported with restenosis. Gender, age, size of the lesion, the status of smoking, history of hypertension, and dyslipidemia were not significantly associated with the recurrence of stenosis, p > 0.05. There was a significant relationship between the vessels involved and the type of revascularization method and the recurrence of the PAD. Endovascular revascularization technique and type of vessel involved in PAD are significant factors contributing to restenosis in our population of study. However, further studies with a greater sample size are required in this area.
- Open Access
- 29 January 2021
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 62, 469-472
Evaluation of one-year incidence of vocal dysfunction and associated demographic factors in thyroidectomy patients: A descriptive analytical study
Background: Voice changes are common complaint following thyroidectomy that might or might not be associated with laryngeal nerve damage. Objective: The aim of this study is to evaluate the effect thyroidectomy on voice alteration and its association with gender and age. Methods: In this descriptive analytical study, patients who underwent thyroidectomy at (XXX) without laryngeal nerve damage were included. These patients were evaluated based on subjective (self-reported) and objective (videostroboscopy) voice assessment. The data was collected immediately after the surgery and 6 months after the surgery during the follow-up. Results: Of 76 patients included, the mean age of patients was 46.3 year. 25 (43.4%) were males and 51 (56.6%) were female. 28.9% patients were presented with apparent damage to the vocal cords, of which 8 (10.5) had voice changes. There was no statistically significant difference between sex and postoperative vocal cord dysfunction (P = 0.592). However, in male gender, late postoperative voice changes were significantly more, p = 0.013. The age was also not associated with immediate or late postoperative changes and damage to vocal cords, p > 0.05. Conclusion: Our study reported that male gender can be an important factor in deterring voice changes after thyroidectomy nonetheless, it can not predict the risk of vocal cord damage. Furthermore, age might not a risk factor either. Studies with greater sample size are required to confirm these findings.
- 29 January 2021
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 62, 469-472
Open AccessEvaluation of one-year incidence of vocal dysfunction and associated demographic factors in thyroidectomy patients: A descriptive analytical study
Background: Voice changes are common complaint following thyroidectomy that might or might not be associated with laryngeal nerve damage. Objective: The aim of this study is to evaluate the effect thyroidectomy on voice alteration and its association with gender and age. Methods: In this descriptive analytical study, patients who underwent thyroidectomy at (XXX) without laryngeal nerve damage were included. These patients were evaluated based on subjective (self-reported) and objective (videostroboscopy) voice assessment. The data was collected immediately after the surgery and 6 months after the surgery during the follow-up. Results: Of 76 patients included, the mean age of patients was 46.3 year. 25 (43.4%) were males and 51 (56.6%) were female. 28.9% patients were presented with apparent damage to the vocal cords, of which 8 (10.5) had voice changes. There was no statistically significant difference between sex and postoperative vocal cord dysfunction (P = 0.592). However, in male gender, late postoperative voice changes were significantly more, p = 0.013. The age was also not associated with immediate or late postoperative changes and damage to vocal cords, p > 0.05. Conclusion: Our study reported that male gender can be an important factor in deterring voice changes after thyroidectomy nonetheless, it can not predict the risk of vocal cord damage. Furthermore, age might not a risk factor either. Studies with greater sample size are required to confirm these findings.
- 13 January 2021
- Published by Bentham Science Publishers Ltd. in Cardiovascular & Hematological Disorders-Drug Targets
- Vol. 20 (4) , 249-259
Atrial Fibrillation and Ventricular Tachyarrhythmias: Advancements for Better Outcomes
Cardiac arrhythmias are associated with several cardiac diseases and are prevalent in people with or without structural and valvular abnormalities. Ventricular arrhythmias (VA) can be life threating and their onset require immediate medical attention. Similarly, atrial fibrillation and flutter lead to stroke, heart failure and even death. Optimal treatment of VA is variable and depends on the medical condition associated with the rhythm disorder (which includes reversible causes such as myocardial ischemia or pro-arrhythmic drugs). While an implanted cardioverter defibrillator is often indicated in secondary prevention of VA. This review highlights the newest advancements in these techniques and management of ventricular and atrial tachyarrhythmias, along with pharmacological therapy.
- 13 January 2021
- Published by Bentham Science Publishers Ltd. in Cardiovascular & Hematological Disorders-Drug Targets
- Vol. 20 (4) , 249-259
Atrial Fibrillation and Ventricular Tachyarrhythmias: Advancements for Better Outcomes
Cardiac arrhythmias are associated with several cardiac diseases and are prevalent in people with or without structural and valvular abnormalities. Ventricular arrhythmias (VA) can be life threating and their onset require immediate medical attention. Similarly, atrial fibrillation and flutter lead to stroke, heart failure and even death. Optimal treatment of VA is variable and depends on the medical condition associated with the rhythm disorder (which includes reversible causes such as myocardial ischemia or pro-arrhythmic drugs). While an implanted cardioverter defibrillator is often indicated in secondary prevention of VA. This review highlights the newest advancements in these techniques and management of ventricular and atrial tachyarrhythmias, along with pharmacological therapy.
- 26 November 2020
- Published by Bentham Science Publishers Ltd. in Cardiovascular & Hematological Disorders-Drug Targets
- Vol. 20 (3) , 221-226
Evaluating Mortality Rate and Associated Parameters in Patients with Acute Coronary Syndrome
Background: Acute coronary syndrome (ACS) is one of the leading causes of mortality worldwide and is characterized by unstable angina or acute myocardial infarction. The aim of this study is to evaluate the clinical characteristics of patients who died of ACS. Methods: In this cross-sectional study, 1000 patients presenting ACS were included. Data and records of these patients were evaluated for parameters such as; deceased status, age, gender, diagnosis, ECG, common complaints, associated risk factors, Killip class, pulse, blood pressure, geographic setup (urban or rural), complications and season in which the disease was presented. Statistical analysis was performed on the data obtained using SPSS-win software. Results: The mortality rate among ACS patients in our study was 7.1%. Of these patients, AMI was the most prevalent diagnosis and chest pain was the most common complaint. Furthermore, low blood pressure, advanced age, increased pulse rate and fall/winter season were associated with the increased risk of mortality. ST deviation was the most seen ECG finding and most of the mortalities were within the 24 hours of admission. Conclusion: Our study reports risk factors associated with mortality in ACS patients. Advanced and timely therapeutic measurements are likely to reduce the incidence of mortality in these patients.
- 26 November 2020
- Published by Bentham Science Publishers Ltd. in Cardiovascular & Hematological Disorders-Drug Targets
- Vol. 20 (3) , 221-226
Evaluating Mortality Rate and Associated Parameters in Patients with Acute Coronary Syndrome
Background: Acute coronary syndrome (ACS) is one of the leading causes of mortality worldwide and is characterized by unstable angina or acute myocardial infarction. The aim of this study is to evaluate the clinical characteristics of patients who died of ACS. Methods: In this cross-sectional study, 1000 patients presenting ACS were included. Data and records of these patients were evaluated for parameters such as; deceased status, age, gender, diagnosis, ECG, common complaints, associated risk factors, Killip class, pulse, blood pressure, geographic setup (urban or rural), complications and season in which the disease was presented. Statistical analysis was performed on the data obtained using SPSS-win software. Results: The mortality rate among ACS patients in our study was 7.1%. Of these patients, AMI was the most prevalent diagnosis and chest pain was the most common complaint. Furthermore, low blood pressure, advanced age, increased pulse rate and fall/winter season were associated with the increased risk of mortality. ST deviation was the most seen ECG finding and most of the mortalities were within the 24 hours of admission. Conclusion: Our study reports risk factors associated with mortality in ACS patients. Advanced and timely therapeutic measurements are likely to reduce the incidence of mortality in these patients.
- 9 July 2020
- Published by Taylor & Francis in Future Cardiology
- Vol. 16 (6) , 675-685
Application of Tissue-Engineered Interventions for Coronary Artery Bypass Grafts
Coronary artery bypass graft is one of the extensively conducted procedures to release occlusion in the coronary vessel. Various biological grafts are used for this purpose, superiorly, saphenous v...
- 9 July 2020
- Published by Taylor & Francis in Future Cardiology
- Vol. 16 (6) , 675-685
Application of Tissue-Engineered Interventions for Coronary Artery Bypass Grafts
Coronary artery bypass graft is one of the extensively conducted procedures to release occlusion in the coronary vessel. Various biological grafts are used for this purpose, superiorly, saphenous v...
- Open Access
- 11 March 2020
- Published by Wiley in Clinical Case Reports
- Vol. 8 (4) , 606-611
Sigmoid volvulus after CABG surgery
We report a case of a geriatric patient who underwent CABG and developed sigmoid volvulus (SV) with recurrence. SV is a rarely reported complication of CABG. Timely diagnosis, management, and follow‐up are strictly advised, particularly in geriatric patients. Immediate surgical measures are required to prevent volvulus‐associated ischemia.
- 11 March 2020
- Published by Wiley in Clinical Case Reports
- Vol. 8 (4) , 606-611
Open AccessSigmoid volvulus after CABG surgery
We report a case of a geriatric patient who underwent CABG and developed sigmoid volvulus (SV) with recurrence. SV is a rarely reported complication of CABG. Timely diagnosis, management, and follow‐up are strictly advised, particularly in geriatric patients. Immediate surgical measures are required to prevent volvulus‐associated ischemia.
- 24 May 2019
- Published by Walter de Gruyter GmbH in Journal of Complementary and Integrative Medicine
- Vol. 16 (4)
The combined effect of vitamin C and omega-3 polyunsaturated fatty acids on fatigue following coronary artery bypass graft surgery: a triple-blind clinical trial
Background: Fatigue is a common compliant among patients who undergo coronary artery bypass graft (CABG) surgery. This may affect patients’ function in all aspects. A few studies have already assessed the influence of complementary therapies on minimizing fatigue. This study aimed to investigate the combined effect of vitamin C and omega-3 polyunsaturated fatty acids (n-3 PUFA) on fatigue following CABG surgery. Methods: In this randomized, triple-blind placebo-controlled trial, 160 patients who already underwent CABG surgery were randomly assigned into an experimental or a control groups. Each group consisted of 80 patients. The experimental group was given both n-3 PUFA and vitamin C the day before surgery. They also received the same supplements in the first 5 days of operation. The control group received only placebo. Subjects in both groups responded to Multidimensional Fatigue Inventory (MFI-20) scale in the beginning, and at the end of the intervention as well as on the fifth day of the operation. Chi-square test and independent t-test were used for data analysis. Results: The mean fatigue score in experimental and control groups came up to 62.01 ± 4.06 and 67.92 ± 4.95 (p<0.0001), respectively, which was greater than that of the values we had before intervention. The mean difference of fatigue score was 3.97 ± 3.49 and 9.56 ± 6.41 (p<0.0001) prior and following the intervention, correspondingly. Conclusion: Combination of vitamin C and n-3 PUFA effectively reduces post-operative fatigue among patients who undergo CABG surgery.
- 24 May 2019
- Published by Walter de Gruyter GmbH in Journal of Complementary and Integrative Medicine
- Vol. 16 (4)
The combined effect of vitamin C and omega-3 polyunsaturated fatty acids on fatigue following coronary artery bypass graft surgery: a triple-blind clinical trial
Background: Fatigue is a common compliant among patients who undergo coronary artery bypass graft (CABG) surgery. This may affect patients’ function in all aspects. A few studies have already assessed the influence of complementary therapies on minimizing fatigue. This study aimed to investigate the combined effect of vitamin C and omega-3 polyunsaturated fatty acids (n-3 PUFA) on fatigue following CABG surgery. Methods: In this randomized, triple-blind placebo-controlled trial, 160 patients who already underwent CABG surgery were randomly assigned into an experimental or a control groups. Each group consisted of 80 patients. The experimental group was given both n-3 PUFA and vitamin C the day before surgery. They also received the same supplements in the first 5 days of operation. The control group received only placebo. Subjects in both groups responded to Multidimensional Fatigue Inventory (MFI-20) scale in the beginning, and at the end of the intervention as well as on the fifth day of the operation. Chi-square test and independent t-test were used for data analysis. Results: The mean fatigue score in experimental and control groups came up to 62.01 ± 4.06 and 67.92 ± 4.95 (p<0.0001), respectively, which was greater than that of the values we had before intervention. The mean difference of fatigue score was 3.97 ± 3.49 and 9.56 ± 6.41 (p<0.0001) prior and following the intervention, correspondingly. Conclusion: Combination of vitamin C and n-3 PUFA effectively reduces post-operative fatigue among patients who undergo CABG surgery.
- 6 April 2019
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 66 (4) , 478-483
A review: Nanofibrous scaffold in possible prevention and treatment of coronary artery disease
Nanofibrous scaffolds have potential to improve coronary stent applications by promoting endothelial recovery on the stent surface and aids regeneration of cardiac tissues. Presently, scaffolds fabricated via electro‐spinning are been widely used because of their ability to bio‐mimic the precise anatomical structure of the protein fibers. Properties like convenience to spin on several components and functionalization with several bioactive molecules have signify the use of nanofibrous scaffolds for tissue engineering. This review highlights some recent applications of electrospun nanofibrous scaffolds in the treatment and management of cardiac arterial diseases and engineering new cardiac tissues.
- 6 April 2019
- Published by Wiley in Biotechnology and Applied Biochemistry
- Vol. 66 (4) , 478-483
A review: Nanofibrous scaffold in possible prevention and treatment of coronary artery disease
Nanofibrous scaffolds have potential to improve coronary stent applications by promoting endothelial recovery on the stent surface and aids regeneration of cardiac tissues. Presently, scaffolds fabricated via electro‐spinning are been widely used because of their ability to bio‐mimic the precise anatomical structure of the protein fibers. Properties like convenience to spin on several components and functionalization with several bioactive molecules have signify the use of nanofibrous scaffolds for tissue engineering. This review highlights some recent applications of electrospun nanofibrous scaffolds in the treatment and management of cardiac arterial diseases and engineering new cardiac tissues.